Market Research Logo

Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review

Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear an


Section 1 - About the Company
Acceleron Pharma Inc - Key Facts
Acceleron Pharma Inc - Key Employees
Acceleron Pharma Inc - Key Employee Biographies
Acceleron Pharma Inc - Major Products and Services
Acceleron Pharma Inc - History
Acceleron Pharma Inc - Company Statement
Acceleron Pharma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
Acceleron Pharma Inc - Business Description
R&D Overview
Acceleron Pharma Inc - Corporate Strategy
Acceleron Pharma Inc - SWOT Analysis
SWOT Analysis - Overview
Acceleron Pharma Inc - Strengths
Acceleron Pharma Inc - Weaknesses
Acceleron Pharma Inc - Opportunities
Acceleron Pharma Inc - Threats
Acceleron Pharma Inc - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Acceleron Pharma Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
Feb 27, 2019: Acceleron reports fourth quarter and full year 2018 operating and financial results
Dec 02, 2018: Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018
Nov 01, 2018: Acceleron Announces that Phase 3 Results from the MEDALIST and BELIEVE Trials of Luspatercept will be Presented at the 60th American Society of Hematology Annual Meeting
Oct 30, 2018: Acceleron reports third quarter 2018 operating and financial results
Oct 16, 2018: Acceleron to Host Pulmonary Arterial Hypertension Research and Development Deep Dive Event on November 16, 2018 in New York City
Aug 02, 2018: Acceleron reports second quarter 2018 operating and financial results
Jul 05, 2018: Acceleron Names Robert K. Zeldin, M.D., Chief Medical Officer
May 08, 2018: Acceleron Reports First Quarter 2018 Operating and Financial Results
Feb 27, 2018: Acceleron Reports Fourth Quarter and Full Year 2017 Operating and Financial Results
Section 6 - Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Acceleron Pharma Inc, Key Facts
Acceleron Pharma Inc, Key Employees
Acceleron Pharma Inc, Key Employee Biographies
Acceleron Pharma Inc, Major Products and Services
Acceleron Pharma Inc, History
Acceleron Pharma Inc, Subsidiaries
Acceleron Pharma Inc, Key Competitors
Acceleron Pharma Inc, Ratios based on current share price
Acceleron Pharma Inc, Annual Ratios
Acceleron Pharma Inc, Annual Ratios (Cont...1)
Acceleron Pharma Inc, Interim Ratios
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Acceleron Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Acceleron Pharma Inc, Performance Chart (2013 - 2017)
Acceleron Pharma Inc, Ratio Charts
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report